Visualization of the sentinel node in early-stage oral cancer: limited value of late static lymphoscintigraphy
Visualization of the sentinel node in early-stage oral cancer: limited value of late static lymphoscintigraphy
复制标题
DOI:
10.1097/mnm.0b013e3283571089
复制
发表时间:
2012-10-01
影响因子:
1.5
通讯作者:
de Bree, Remco
中科院分区:
文献类型:
--
作者:
Heuveling, Derrek A.;Flach, Geke B.;de Bree, Remco
Objective Various lymphoscintigraphic imaging protocols exist for sentinel node (SN) identification in early-stage oral cancer. This study aimed to evaluate the clinical value of performing additional late lymphoscintigraphic imaging.Methods We retrospectively analysed early (directly following injection of Tc-99m-Nanocoll) and late (2-4 h after injection) imaging results of 60 early-stage (T1-T2, cN0) oral cancer patients scheduled for SN procedure. Lymphoscintigraphic results of late imaging were categorized into: (a) no visualization of additional hotspots considered to be SNs; (b) additional hotspots visualized that are considered to be SNs and (c) hotspots visualized only during late imaging. Histopathological results of the harvested SNs were related to the corresponding hotspot.Results In all patients (n=60) lymphoscintigraphy was able to visualize a hotspot that was identified as an SN. In 51/60 (85%) patients, early imaging was able to visualize at least one hotspot, whereas in 9/60 (15%) patients, mostly with oral cavity tumours other than mobile tongue and floor-of-mouth tumours, only late imaging was able to visualize hotspots. In 14/51 (27%) patients, late imaging resulted in additionally visualized hotspots marked as SNs, resulting in a more extensive surgical procedure. These additionally removed SNs appeared to be of no clinical relevance, as all SNs identified during early imaging correctly predicted whether the neck was positive or negative for cancer.Conclusion Results of this study indicate that additional late lymphoscintigraphic imaging should be performed only in selected cases. Nucl Med Commun 33:1065-1069 (C) 2012 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.